Table 3.
Comparison of clinical features of hypertensive patients taking different antihypertensive drugs.
| ACEI or ARB (n = 15) |
Other antihypertensive drugs (n = 21) |
P Valuea | |
|---|---|---|---|
| Age, years, mean (SD) | 58.5(10.1) | 69.2(7.5) | .001 |
| Sex | |||
| Female | 6(40.0%) | 11(52.4%) | .516 |
| Male | 9(60.0%) | 10(47.6%) | |
| Lymphocyte count, ×109/L, mean (SD) | 0.87(0.33) | 1.02(0.17) | .237 |
| Prognosis | |||
| Clinical cure | 10(66.7%) | 15(71.4%) | >0.99 |
| Transfer to high-level hospital | 3(20.0%) | 1(4.8%) | .287 |
| Clinical death | 2(13.3%) | 5(23.8%) | .676 |
| Onset of symptom to hospital admission, days, mean (SD) | 9.6(4.0) | 8.6(5.2) | .528 |
| Hospitalization time, days, mean (SD) | 10.1(5.2) | 11.7(6.0) | .405 |
aP values indicate differences between ACEI or ARB group and other antihypertensive drug groups. P < 0.05 was considered statistically significant. Means of two groups were tested for statistical difference using unpaired Student’s t-test. The distribution of categorical variables was evaluated using Chi-square test.